ISELIN, N.J., Feb. 26 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, drug delivery products and other surgical implants, announced today that Robert P. Hickey, President and CEO, will present at the Canaccord Adams' Small-Cap Orthopedics conference on March 4, 2008 at 3:30 p.m. PST in San Francisco, CA. Mr. Hickey will present a company overview.
The presentation will be Web cast live and available for 90 days beginning on March 4, 2008, and can be heard by clicking on the following link: http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2186580
About SyntheMed, Inc.
SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion products, drug delivery products and other surgical implants. The company is primarily focused on the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technology.
Statements in this Press Release that are not statements of historical fact, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Reference is made to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 for a description of these, as well as other, risks and uncertainties.
|SOURCE SyntheMed, Inc.|
Copyright©2008 PR Newswire.
All rights reserved